Goldman Sachs’s Palvella Therapeutics PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.2M Buy
194,179
+95,244
+96% +$9.94M ﹤0.01% 2256
2025
Q4
$10.4M Sell
98,935
-137,695
-58% -$11.7M ﹤0.01% 3065
2025
Q3
$14.8M Buy
236,630
+151,301
+177% +$6.75M ﹤0.01% 2569
2025
Q2
$1.92M Buy
85,329
+66,276
+348% +$1.56M ﹤0.01% 4214
2025
Q1
$533K Buy
+19,053
New +$367K ﹤0.01% 5148
2024
Q2
Sell
-283
Closed -$332K 5985
2024
Q1
$332K Hold
283
﹤0.01% 4927
2023
Q4
$4.12K Hold
283
﹤0.01% 5538
2023
Q3
$6.74K Sell
283
-28
-9% -$602 ﹤0.01% 5425
2023
Q2
$4.11K Sell
311
-303
-49% -$18.4K ﹤0.01% 5645
2023
Q1
$47.9K Sell
614
-8
-1% -$926 ﹤0.01% 5561
2022
Q4
$51.7K Sell
622
-187
-23% -$15K ﹤0.01% 5592
2022
Q3
$74K Sell
809
-185
-19% -$23.9K ﹤0.01% 5750
2022
Q2
$149K Sell
994
-1,444
-59% -$263K ﹤0.01% 5739
2022
Q1
$591K Sell
2,438
-3,595
-60% -$945K ﹤0.01% 5205
2021
Q4
$1.82M Sell
6,033
-199
-3% -$63.7K ﹤0.01% 4325
2021
Q3
$2.58M Buy
6,232
+5,966
+2,243% +$2.08M ﹤0.01% 3952
2021
Q2
$82K Sell
266
-2,699
-91% -$592K ﹤0.01% 5988
2021
Q1
$609K Sell
2,965
-925
-24% -$202K ﹤0.01% 4970
2020
Q4
$778K Sell
3,890
-324
-8% -$67.4K ﹤0.01% 4352
2020
Q3
$697K Sell
4,214
-232
-5% -$52.8K ﹤0.01% 4298
2020
Q2
$1.1M Buy
4,446
+281
+7% +$65.7K ﹤0.01% 3879
2020
Q1
$759K Buy
4,165
+386
+10% +$97.3K ﹤0.01% 3942
2019
Q4
$1.09M Sell
3,779
-423
-10% -$117K ﹤0.01% 4071
2019
Q3
$1.15M Sell
4,202
-1,723
-29% -$667K ﹤0.01% 3934
2019
Q2
$2.23M Sell
5,925
-855
-13% -$255K ﹤0.01% 3470
2019
Q1
$1.82M Sell
6,780
-1,031
-13% -$245K ﹤0.01% 3701
2018
Q4
$1.66M Sell
7,811
-203
-3% -$63K ﹤0.01% 3645
2018
Q3
$3.59M Sell
8,014
-724
-8% -$315K ﹤0.01% 3217
2018
Q2
$3.54M Buy
8,738
+400
+5% +$190K ﹤0.01% 3206
2018
Q1
$4.55M Buy
8,338
+5,060
+154% +$3.13M ﹤0.01% 2976
2017
Q4
$1.98M Buy
3,278
+2,030
+163% +$944K ﹤0.01% 3812
2017
Q3
$575K Buy
1,248
+1,099
+738% +$469K ﹤0.01% 4999
2017
Q2
$60K Buy
+149
New +$43.5K ﹤0.01% 6317

Other funds holding PVLA